SMC2 abundance was significantly associated with shorter OS in stage I and stage II and AJCC-T2 HCC patients, and SMC6 expression was significantly correlated with poorer OS in AJCC-T1 HCC patients. The gene discussed is SMC2; the disease is hepatocellular carcinoma.